Management of Acute Appendicitis
Laparoscopic appendectomy remains the gold standard treatment for acute appendicitis, but antibiotic therapy is a safe and effective alternative for selected patients with uncomplicated appendicitis without appendicolith. 1
Initial Approach: Uncomplicated vs Complicated Disease
The management pathway fundamentally depends on whether appendicitis is uncomplicated or complicated:
Uncomplicated Acute Appendicitis
Two evidence-based options exist:
Option 1: Laparoscopic Appendectomy (Preferred Standard)
- Perform laparoscopic appendectomy within 24 hours of admission 1
- Laparoscopic approach offers superior outcomes over open surgery: less pain, lower surgical site infection rates, shorter hospital stay, faster return to work, and better quality of life 1
- Delays beyond 24 hours increase adverse outcomes and should be avoided 1
- Single preoperative dose of broad-spectrum antibiotics (0-60 minutes before incision) 1
- No postoperative antibiotics needed for uncomplicated cases 1
Option 2: Antibiotic-First Strategy (Selected Patients)
This approach is appropriate ONLY when:
- No appendicolith on imaging (critical exclusion criterion) 1
- Patient accepts 38% recurrence risk at 10 years 2
- Patient understands potential for misdiagnosed complicated disease 1
Antibiotic regimen:
- Start with IV antibiotics, then switch to oral based on clinical response 1
- The 10-year APPAC trial data shows 37.8% true recurrence rate and 44.3% cumulative appendectomy rate, but significantly lower complications (8.5% vs 27.4%) compared to immediate surgery 2
Critical caveat: CT findings of appendicolith, mass effect, or appendiceal diameter >13mm predict ~40% antibiotic failure and mandate surgical management 3
Complicated Appendicitis (Perforation, Phlegmon, or Abscess)
Management algorithm:
If Advanced Laparoscopic Expertise Available:
- Laparoscopic appendectomy is the treatment of choice 1
- Perform within 8 hours for pediatric complicated cases 1
- Associated with fewer readmissions and interventions than conservative treatment 1
- Use suction alone (NOT irrigation/lavage) for intra-abdominal collections 1
- No routine drain placement 4
If Laparoscopic Expertise NOT Available:
Postoperative antibiotics for complicated disease:
- Limit to 3-5 days maximum with adequate source control 1
- In children: switch to oral after 48 hours, total duration <7 days 1
- Longer courses provide no benefit and increase costs 1
Interval Appendectomy Decisions
Do NOT perform routine interval appendectomy after successful non-operative management in patients <40 years old 1
- Recurrence rate is 12-24%, but interval appendectomy only prevents recurrence in 1 of 8 patients 1
- Only perform if symptoms recur 1
Exception for patients ≥40 years old:
- Perform colonoscopy AND interval contrast-enhanced CT scan 1
- Appendiceal neoplasm incidence is 3-17% in this age group 1
Special Populations
Pregnant patients:
- Laparoscopic appendectomy is safe and preferred over open surgery 1
- Short delays with repeat ultrasound acceptable if diagnosis equivocal 1
Pediatric patients:
- Laparoscopic appendectomy preferred 1
- Recent 2026 meta-analysis shows significantly higher treatment failure and major complications with antibiotics in children 5
- NOM in children shows 18.47% recurrence rate and higher Clavien-Dindo ≥IIIb complications (RR 33.37) 5
- If surgery delayed, perform within 24 hours; within 8 hours for complicated cases 1
Obese, elderly, or high-risk patients:
- Laparoscopic approach particularly beneficial 1
Common Pitfalls to Avoid
- Missing appendicolith on imaging - This predicts antibiotic failure and mandates surgery 1, 3
- Delaying surgery beyond 24 hours - Increases adverse outcomes 1
- Prolonging antibiotics beyond 3-5 days in complicated cases with source control - No benefit, increased costs 1
- Performing routine interval appendectomy in young patients - Not cost-effective 1
- Using irrigation during laparoscopy - Suction alone is superior 1
- Skipping cancer screening in patients ≥40 treated non-operatively - High neoplasm risk 1